Target intelligence / Profile preview

Basic helix-loop-helix ARNT-like protein 1 (BMAL1)

Target
BMAL1
Molecular classification
Transcription factor
01

Overview

Basic helix-loop-helix ARNT-like protein 1 (BMAL1), encoded by the ARNTL gene, is a core transcription factor of the mammalian molecular circadian clock. BMAL1 heterodimerizes with CLOCK or NPAS2 to bind E-box elements in target gene promoters, driving the rhythmic expression of core clock genes (such as PER and CRY) and hundreds of clock-controlled genes involved in metabolism, immunity, and cell cycle regulation. Dysregulation of BMAL1 is strongly associated with circadian rhythm sleep disorders, metabolic syndrome, cardiovascular diseases, neurodegeneration, and cancer. Pharmacological targeting of BMAL1 has emerged as a promising therapeutic strategy, with the development of direct small-molecule ligands like Core Circadian Modulator (CCM) that bind to its PAS-B domain to allosterically modulate its transcriptional activity and downregulate inflammatory pathways. However, therapeutic intervention carries significant safety concerns, including potential circadian desynchrony, metabolic disruption, and altered blood-brain barrier integrity.

Other names
Aryl hydrocarbon receptor nuclear translocator-like protein 1ARNTLBrain and muscle ARNT-like 1MOP3PASD3bHLHe5JAP3TICARNTL1
02

Mechanism of action

Allosteric modulation of the PAS-B domain, disruption of CLOCK-BMAL1 heterodimerization, and inhibition of CLOCK-BMAL1 DNA binding

03

Biological functions

Circadian rhythm regulationMetabolic regulationImmune response modulationCell cycle regulationTranscription regulation
04

Disease associations

Circadian rhythm disorderMetabolic syndromeCancerInflammationNeurodegenerative diseaseCardiovascular diseaseDepression
05

Safety considerations

Circadian desynchronyHormonal imbalancesMetabolic disruptionPotential for mood alterationsInterference with chronopharmacology of co-administered medicationsBlood-brain barrier hyperpermeabilityAstroglial activation
06

Interacting drugs

Core Circadian Modulator (CCM)

9 more in the full profile.

07

Biomarkers

Dim Light Melatonin Onset (DLMO)Diurnal cortisol rhythmPER1 mRNA expression levelPER2 mRNA expression levelBMAL1 mRNA expression levelBody temperature phase

Beyond the preview

Go deeper on Basic helix-loop-helix ARNT-like protein 1 (BMAL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basic helix-loop-helix ARNT-like protein 1 (BMAL1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call